2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Hereditary Cancer Syndromes: Genetic counseling and testing strategies.
Hereditary cancer syndromes highlight the importance of genetic counseling and testing in cancer prevention and management. Syndromes such as those associated with BRCA1, BRCA2, or Lynch syndrome increase susceptibility to cancers like breast, ovarian, and colorectal. Genetic testing identifies individuals carrying high-risk mutations, allowing for early interventions and personalized management plans. Genetic counselors play a critical role in guiding patients through this process, interpreting test results, and discussing options such as enhanced surveillance, risk-reducing surgeries, or chemoprevention. Beyond medical implications, counseling addresses the emotional impact of genetic findings on individuals and their families. Advances in testing technology, including multi-gene panels, enable the identification of broader genetic risks. By promoting early detection and preventive measures, genetic counseling and testing empower individuals to make informed decisions, reducing the burden of hereditary cancers and improving long-term outcomes.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China